Tallaaladu waa hub adduunku uga adkaado cudurka sambabada ee taajka cusub.Mar kasta oo dadku ay si dhakhso ah u dhammaystiri karaan tallaalka, way fiicnaan doontaa in waddamadu si degdeg ah u xakameeyaan faafitaanka oo ay uga fogaadaan faafitaanka fayraska si baaxad leh.

Sida lagu sheegay warbixin ay Bloomberg soo saartay 3-aad, tirada qiyaasta tallaalka adduunka ayaa gaartay 2 bilyan oo qiyaasood, waxayna qaadatay in ka badan 6 bilood in la gaaro heerkan muhiimka ah.Heerka tallaalka ee 75% waa heerka laga gaarayo difaaca xoolaha.Heerka hadda la joogo, waxay qaadan doontaa ilaa 9 bilood in la tallaalo 75% dadka adduunka.

Laga bilaabo Juun 19, Tirakoobyada Xogta Adduunkeena ee Jaamacadda Oxford ayaa soo warisay 2625200905 qiyaasood oo ah tallaalka fayraska cusub ee adduunka oo dhan, iyadoo heerka tallaalka uu yahay 21.67%.Dadaallada lagu abuurayo tallaal badbaado leh oo COVID-19 ah oo adduunka oo dhan ah ayaa midho dhalaya.Hadda, ku dhawaad ​​20 tallaal ayaa la ansixiyay adduunka oo dhan;qaar kale oo badan ayaa weli ku jira horumarka.

Qiyaaso badan ayaa imanaya

Sababta ugu weyn ee COVAX ay u seegtay yoolkeedii ilaa hadda waa in ay heysatay lacag yar sanadkii hore si ay ugu iibiso tallaalada, waxayna si weyn ugu tiirsan tahay Machadka Serum Institute of India si ay u keento qiyaaso ilaa shirkado badan ay ku bixiyaan alaab la xaqiijiyay oo qiimo jaban ah.LaakinSerumwaxay joojisay dhoofinta qiyaasihii la ballanqaaday bishii Maarso, markii kiisaska COVID-19 ee Hindiya ay qarxeen.Kor u kacaas ayaa hadda gaaray heerkii ugu sarreeyay, shirkadduna waxay kor u qaadday wax soo saarkeeda ilaa 60 milyan oo qiyaasood oo tallaalka AstraZeneca bishii ilaa 100 milyan oo qiyaasood bishan.Awooddu waxay gaari kartaa 250 milyan oo qiyaasood bishiiba dhammaadka sanadka, shirkaddu waxay u sheegaysaa Sayniska.Hogaamiyayaasha COVAX waxay rajeynayaan in shirkadu dib u bilaabi karto dhoofinta isla bisha Sebtembar.

Novavax, oo hadda soo warisay in tallaalkeedu leeyahay90% waxtarkatijaabo weynoo ay maalgelisay dawladda Maraykanka, waxa ay ku biirtay xoogaga Serum sidoo kale.Si wada jir ah, shirkaduhu waxay keeni karaan 1.1 bilyan oo qiyaasood COVAX sanadka 2022 kuwaas oo bilaabi kara hubka deyrtan haddii Novavax jab uu dhaafo maamulayaasha.Nafleyda E, warshad kale oo Hindi ah, ayaa qorsheyneysa inay siiso COVAX 200 milyan oo qiyaasood oo ah tallaalka Johnson & Johnson ee horey loo oggolaaday, kaas oo bilaabaya inuu ka soo baxo khadadka wax soo saarka Sebtembar.

Tallaalada ay soo saareen iskaashiga Pfizer-BioNTech iyo Moderna ayaa laga yaabaa inay door weyn ka ciyaaraan COVAX sidii la filayay, sidoo kale.Shirkadahani waxay ku sameeyaan tallaalo leh Messenger RNA, kaas oo u baahan heerkulka eber ka hooseeya inta lagu jiro gaadiidka ka dibna kaliya ku jiri kara cusub qaboojiyaha caadiga ah muddo bil ah.Xikmad dhaqameed ayaa muddo dheer haysatay in shuruudahaas, oo ay weheliso qiimayaasha sare ee tallaallada, ay la macno tahay inaan lagu isticmaali karin adduunka intiisa badan.Laakiin 10kii Juun, dawladda Mareykanka - oo siisay COVAX $ 2 bilyan - ayaa ku dhawaaqday inay ku deeqi doonto 200 milyan oo qiyaasood oo tallaalka Pfizer ah COVAX sannadkan iyo 300 milyan oo kale marka la gaaro Juun 2022, iyadooUPS Foundationku deeqida qaboojiyaha wadamada u baahan in laga caawiyo kaydinta.(Ma cadda in deeqdani ay beddeleyso ballan-qaadkii dowladda Mareykanka ee ahaa in COVAX ay siiso $2 bilyan oo dheeri ah.) Moderna waxay jartay heshiis ay la gashay COVAX si ay u iibiso illaa 500 milyan oo qiyaasood oo tallaalkiisa ah dhammaadka 2022.

Qadar aad u badan oo tallaal ah ayaa laga yaabaa inuu COVAX uga yimaado ilo kale: Shiinaha.WHO ayaa dhawaan siisay "liiska isticmaalka degdega ah" - looga baahan yahay COVAX - laba warshadood oo Shiinees ah,SinopharmiyoShirkadda Sinovac Biotech, kuwaas oo soo saaray ku dhawaad ​​kala badh dhammaan tallaallada laga bixiyo adduunka oo dhan ilaa maanta.Berkley ayaa sheegay in kooxdiisa Gavi, oo wax ka iibsata COVAX, ay kala xaajoonayaan heshiisyada labada shirkadood.